SID 18: Organ Transplant


1⃣ Interplay Between Host Immune System & Immunosuppression

The core problem in transplant patients

Your immune system’s job is to detect foreign material and destroy it.

Unfortunately, a transplanted organ looks foreign to the immune system.

So the immune system tries to attack it → allograft rejection.

Transplant medicine therefore has to balance two competing risks:

Too little immunosuppression → organ rejection
Too much immunosuppression → infections & malignancy

This balance is shown conceptually in the lecture as a scale between:

  • Opportunistic infections and

  • Graft rejection.


Quick immune system refresher

Two arms of immunity matter here.

Innate immunity (fast)

  • Neutrophils

  • Macrophages

  • NK cells

  • Complement

Adaptive immunity (targeted)

  • T cells

  • B cells

Adaptive immunity is the main driver of transplant rejection.

Key functions:

Cell

Role

CD4 T cells

coordinate immune response

CD8 T cells

destroy infected/foreign cells

B cells

produce antibodies


Why immunosuppressants target T-cells

Transplant rejection is largely T-cell mediated.

T cells recognize donor antigens → activate cytokines → destroy graft tissue.

Therefore most transplant drugs aim to:

🛑 Block T-cell activation
🛑 Block T-cell proliferation
🛑 Reduce antibody formation


2⃣ Timing of Opportunistic Infections After Transplant

The type of infection strongly depends on how long after transplant the patient is.

Your exam will absolutely test this.

Infection timeline

Time after transplant

Typical infections

Early (< 4 weeks)

Surgical / hospital infections

Intermediate (1–12 months)

Opportunistic infections

Late (>12 months)

Community infections


Early period (<4 weeks)

Cause:

  • surgery

  • hospital exposure

  • donor infections

Common infections:

  • surgical wound infections

  • catheter infections

  • nosocomial pneumonia

  • UTIs

Usually bacterial.


Intermediate period (1–12 months)

This is when immunosuppression is highest.

Classic opportunistic infections appear:

🦠 Viruses

  • CMV

  • EBV

  • BK virus

  • HSV

🍄 Fungi

  • Candida

  • Aspergillus

  • Pneumocystis jirovecii

🦠 Bacteria

  • Listeria

  • Nocardia

  • Mycobacteria


Late period (>12 months)

Immunosuppression is lower.

Infections resemble general population infections:

  • community respiratory viruses

  • pneumonia

  • UTIs

Unless:

  • patient is over-immunosuppressed

  • graft rejection treatment increases immunosuppression


3⃣ Immunosuppressive Agents

Maintenance therapy usually uses 3 drugs together.

Why?

Different mechanisms → lower doses → fewer toxicities.

Typical regimen:

💊 Calcineurin inhibitor
💊 Antimetabolite
💊 Corticosteroid


3A️⃣ Calcineurin Inhibitors (CNIs)

Drugs:

  • Tacrolimus

  • Cyclosporine

These are the backbone of transplant therapy.

Mechanism

They block calcineurin, which prevents IL-2 transcription.

IL-2 is required for T-cell activation and proliferation.

Result:

🚫 ↓ T-cell activation
🚫 ↓ immune response
🚫 ↓ rejection

Differences

Feature

Tacrolimus

Cyclosporine

Preference

Preferred

Used less often

Metabolism

CYP3A4

CYP3A4

Monitoring

trough levels

trough or C2

Unique ADRs

neurotoxicity, hyperglycemia

hirsutism, gingival hyperplasia

Shared ADRs

nephrotoxicity, HTN

Tacrolimus is usually preferred because it has:

lower rejection rates
better graft survival


3B️⃣ mTOR Inhibitor

Drug:

  • Sirolimus

Mechanism

Blocks mTOR, which stops cell cycle progression.

Result:

🛑 (STOPS) T-cell proliferation
🛑 (STOPS) B-cell proliferation

Important exam point

NOT used immediately after transplant.

Why?

It causes:

  • impaired wound healing

  • thrombosis risk

  • delayed graft function

Therefore it's used when:

  • CNI toxicity occurs

  • malignancy develops

  • persistent rejection


3C️⃣ Antimetabolites

Drugs:

  • Mycophenolate

  • Azathioprine

These block DNA synthesis in immune cells.

Mycophenolate

Mechanism:

Blocks inosine monophosphate dehydrogenase (IMPDH) → prevents guanosine synthesis.

Result:

🚫 T-cell proliferation
🚫 B-cell proliferation

Common ADRs:

  • diarrhea

  • leukopenia

  • hepatotoxicity

Preferred agent because it causes less bone marrow toxicity than azathioprine.

Azathioprine

Prodrug → converted to 6-mercaptopurine.

Mechanism:

🧬 blocks purine synthesis → impaired DNA replication.

Main toxicity:

💀 bone marrow suppression


3D️⃣ Corticosteroids

Drug:

  • Prednisone

These have broad immunosuppressive effects.

They:

  • decrease lymphocyte activity

  • reduce antibody production

  • reduce inflammatory cytokines

Major steroid adverse effects

Common ones your prof might test:

  • hyperglycemia

  • osteoporosis

  • hypertension

  • weight gain

  • mood changes

  • infections


4⃣ Drug-Drug Interactions (Very High Yield)

Most immunosuppressants are metabolized by:

CYP3A4

So many interactions occur.

Drugs that DECREASE tacrolimus/cyclosporine levels

(CYP3A4 inducers)

Examples:

  • phenytoin

  • carbamazepine

  • phenobarbital

  • rifampin

Effect:

tacrolimus levels
immunosuppression
rejection risk

Management:

  • increase dose

  • monitor levels

Drugs that INCREASE tacrolimus levels

(CYP3A4 inhibitors)

Examples:

  • azole antifungals

  • macrolides

  • diltiazem

  • verapamil

  • amiodarone

  • ritonavir (Paxlovid)

Effect:

tacrolimus levels
toxicity (nephrotoxicity, neurotoxicity)

Management:

  • reduce dose

  • monitor troughs


5⃣ Opportunistic Infection Prophylaxis

Your exam will probably ask which prophylaxis to use.


CMV prophylaxis

Drug:

💊 Valganciclovir

MOA:

Nucleoside analogue → inhibits viral DNA polymerase.

Risk depends on donor/recipient status

Donor

Recipient

Risk

Low

+

+ or –

Intermediate

**+

–**

Highest risk

High risk → prophylaxis 3–12 months.


HSV prophylaxis

Most severe reactivation occurs first month post-transplant.

Prophylaxis used when:

  • patient not receiving CMV prophylaxis

Drug:

💊 Valacyclovir

Duration:

~3 months


PJP prophylaxis

Most important opportunistic infection prophylaxis.

Preferred drug:

💊 TMP-SMX

Options:

Regimen

1 SS daily

1 DS three times weekly

Duration:

  • 12 months after transplant

  • lifelong in lung transplant

Alternatives if sulfa allergy:

  • dapsone

  • pentamidine

  • atovaquone


High-Yield Exam Summary

If I were writing your exam questions, these are the 10 things I would test.

1⃣ Immunosuppression = balance between rejection vs infection

2⃣ T-cells drive transplant rejection

3⃣ Infection timing

  • <4 weeks → surgical/hospital

  • 1–12 months → opportunistic

12 months → community infections

4⃣ Maintenance regimen

  • CNI + antimetabolite + steroid

5⃣ Tacrolimus preferred over cyclosporine

6⃣ Calcineurin inhibitors block IL-2 transcription

7⃣ Mycophenolate blocks IMPDH

8⃣ Sirolimus blocks mTOR

9⃣ CYP3A4 interactions are critical

10⃣ Prophylaxis

  • CMV → valganciclovir

  • HSV → valacyclovir

  • PJP → TMP-SMX